Home › Funds › CAPITAL COUNSEL LLC/NY › MRNA

CAPITAL COUNSEL LLC/NY position in MRNA

MODERNA INC · Health Care

CAPITAL COUNSEL LLC/NY reported holding 6,172 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$1.2M, representing 0.05% of its reported portfolio and ranking #30 among its reported holdings. CAPITAL COUNSEL LLC/NY has disclosed MRNA holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)6.17K sh
Reported value held$1.19M
Portfolio Weight0.05%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CAPITAL COUNSEL LLC/NY's MRNA position evolved

CAPITAL COUNSEL LLC/NY first disclosed a stake in MRNA in Q3 2023 at 10,571 shares (US$1.1M). The position peaked in Q3 2026 at 6,172 shares, worth US$1.2M. Across 10 filings, CAPITAL COUNSEL LLC/NY increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 6,172 shares valued at US$1.2M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 10.57K $1.09M New
Q4 2023 10.40K $1.03M Reduce
Q1 2024 9.97K $1.06M Reduce
Q2 2024 9.07K $1.08M Reduce
Q3 2024 9.07K $606.15K Hold
Q4 2024 8.74K $363.41K Reduce
Q1 2025 8.73K $247.41K Hold
Q1 2026 6.20K $315.06K New
Q2 2026 6.17K $432.23K Hold
Q3 2026 6.17K $1.19M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 42 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has CAPITAL COUNSEL LLC/NY held MRNA?

CAPITAL COUNSEL LLC/NY has disclosed MRNA holdings in 10 of the last 13 reported quarters, going back to Q3 2023.

What is CAPITAL COUNSEL LLC/NY's current position in MRNA?

As of Q3 2026, CAPITAL COUNSEL LLC/NY holds 6.17K shares of MRNA (MODERNA INC), valued at $1.19M, representing 0.05% of its reported portfolio and ranking #30.

Has CAPITAL COUNSEL LLC/NY been buying or selling MRNA?

In the latest 13F filing (Q3 2026), CAPITAL COUNSEL LLC/NY held unchanged its position in MRNA. The position peaked in Q3 2026 at 6.17K shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.